Thromboinflammatory response in SARS-CoV-2 sepsis.
Med Leg J
; 88(2): 78-80, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-506028
ABSTRACT
Viral sepsis is rare, and its real incidence is not known. SARS-CoV-2 infection causes the release of a significant amount of pro-inflammatory cytokines that aggravates interstitial pneumonia and evolves in viral sepsis with prominent hypercoagulability. We believe it is useful and advisable to establish early immunomodulator therapy and the prophylaxis anticoagulant therapy should be rethought.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Thrombosis
/
Cytokines
/
Coronavirus Infections
/
Sepsis
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Med Leg J
Year:
2020
Document Type:
Article
Affiliation country:
0025817220926915
Similar
MEDLINE
...
LILACS
LIS